Skip to content
S7870Senate2021-2022 SessionSame asA8757

Direct Opioid Settlement Funds

Official title

“Relates to statewide opioid settlements and the opioid settlement fund”

Sponsor Gustavo RiveraSD-33Affects Finance
Status
Signed by Governor
Impact
8/10
Significant
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill updates state law to ensure opioid settlement funds are spent according to statewide agreements, with expanded oversight and reporting requirements.

Why it matters

  1. Ensures that opioid settlement funds are strictly used for approved purposes. by tying expenditures and fund definitions to the specific terms of statewide settlement agreements, aiming to prevent the diversion of these funds for unrelated state budget needs.

  2. Expands and clarifies oversight and transparency. , including more detailed annual public reporting on how funds are distributed, spent, and the outcomes achieved, which can help advocates and the public monitor for misuse or inefficiency.

  3. Broadens the advisory board and its expertise. by increasing its size, diversifying appointments, and mandating inclusion of members with backgrounds in public finance, lived experience, and communities disproportionately affected by addiction, which may influence more equitable and effective funding decisions.

  4. Strengthens accountability for local governments and agencies. by requiring annual certifications and detailed reporting from recipients of settlement funds, potentially improving the quality and targeting of opioid-related programs across New York State.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Direct Opioid Settlement Funds

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

No co-sponsors yet.

History

  1. Signed chap.171
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading cal.400
  6. Substituted for A8757
  7. Referred to ways and means
  8. Delivered to assembly
  9. Passed senateVote 63–0
  10. Ordered to third reading cal.207
  11. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8757Assembly

Set Opioid Settlement Fund Rules

Assembly Floor Calendar · Sponsor Carrie Woerner

Impact 8 · Significant0% to pass

Full text

8 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7870

IN SENATE

January 14, 2022

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the state finance law, the mental hygiene law and the executive law, in relation to establishing an opioid settlement fund

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivisions 3, 4 and 5 of section 99-nn of the state finance law, as added by chapter 190 of the laws of 2021, are amended to read as follows:

3. Money expended from such fund shall be used consistent with the terms of any statewide opioid settlement agreements as defined in section 25.18 of the mental hygiene law. Moneys of the fund shall be used to supplement and not supplant or replace any other funds, including federal or state funding, which would otherwise have been expended for substance use disorder prevention, treatment, recovery or harm reduction services or programs. [Provided further, general operating funds or baseline funding shall not be reduced due to monies expended from the fund.]

4. [Such] Notwithstanding subdivision eleven of section four of this chapter, such fund shall consist of money received by the state [as a result of the settlement of litigation with entities that manufactured, sold, distributed, dispensed or promoted opioids, made in connection with claims arising from the manufacturing, marketing, distributing, promoting or dispensing of opioids, as well as any funds received by the state as a result of a judgment, stipulation, decree, agreement to settle, assurance of discontinuance, or other legal instrument resolving any claim or cause of action against manufacturers, distributors, dispensers or vendors of opioids and related entities arising out of activities alleged to have contributed to increases in opioid addiction, whether filed or unfiled, actual or potential, and whether arising under common law, equity, or any provision of law, and all other monies appropriated, credited, or transferred thereto from any other fund or source pursuant to law] pursuant to any statewide opioid settlement agreements as defined in section 25.18 of the mental hygiene law. All [monies]

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD10289-22-2

moneys shall remain in such fund unless and until directed by statute or appropriation.

5. Notwithstanding subdivision eleven of section four of this chapter, or subdivision sixteen of section sixty-three of the executive law, [monies] moneys from the opioid settlement fund shall be available following appropriation by the legislature and shall only be expended on eligible expenditures as defined in section 25.18 of the mental hygiene law for prevention, treatment, harm reduction and recovery services related to substance use disorders and co-occurring mental illnesses in New York state pursuant to the terms of the statewide opioid settlement agreements as defined in section 25.18 of the mental hygiene law. Funding shall be distributed regionally and to ensure adequate geographic disbursement across the state in accordance with the statewide opioid settlement agreements. In addition to programs and services overseen by the office of addiction services and supports, funding may also be expended on programs and services overseen by the department of health, the office of mental health, the division of housing and community renewal or any other agency that may oversee an appropriate program or service that is considered an eligible expenditure as provided under section 25.18 of the mental hygiene law. Funding decisions shall include an emphasis on supporting programs that are culturally, linguistically and gender competent, trauma-informed, evidence-based and, where appropriate, employ individuals with lived experience as part of the services provided.

§ 2. Section 25.18 of the mental hygiene law, as added by chapter 190 of the laws of 2021, is amended to read as follows: § 25.18 Statewide opioid settlements.

(a) Definitions. As used in this section, the following terms shall have the following meanings: 1. Eligible expenditures shall include services and programs that are consistent with the approved uses and terms of the statewide opioid settlement agreement [and] as defined in this section, which may only include [but not be limited to, programs]:

(i) to prevent substance use disorders through an evidence-based youth-focused public health education and prevention campaign, including school-based prevention and health care services and programs to reduce the risk of substance use by school-aged children;

(ii) to develop and implement statewide public education campaigns to reduce stigma against individuals with a substance use disorder, provide information about the risks of substance use, best practices for addressing substance use disorders, and information on how to locate services that reduce the adverse health consequences associated with substance use disorders or provide treatment for substance use disorders;

(iii) to provide substance use disorder treatment and early recovery programs for youth and adults, with an emphasis on programs that provide a continuum of care that includes screening and assessment for substance use disorders and co-occurring disorders, active treatment, family involvement, case management, relapse management for substance use and other co-occurring behavioral health disorders, vocational services, literacy services, parenting classes, family therapy and counseling services, crisis services, recovery services, evidence-based treatments, medication-assisted treatments, including medication assisted treatment provided in correctional facilities, psychiatric medication, psychotherapy and transitional services programs;

(iv) to provide harm reduction counseling and services to reduce the adverse health consequences associated with substance use disorders, including overdose prevention and prevention of communicable diseases related to substance use, provided by a substance use disorder service provider or qualified community-based organization;

(v) to provide housing services for people who are recovering from a substance use disorder. Such housing services shall be appropriate, based on the individual's current need and stage of recovery. Such housing services may include but are not limited to supportive housing services;

(vi) to support community-based programs that reduce the likelihood of criminal justice involvement for individuals who have or are at risk of having a substance use disorder;

(vii) to provide programs for pregnant women and new parents who currently or formerly have had a substance use disorder and newborns with neonatal abstinence syndrome; [and] and/or

(viii) to provide vocational and educational training for individuals with or at risk for a substance use disorder.

2. "Government entity" means (i) departments, agencies, divisions, boards, commissions and/or instrumentalities of the state of New York [including], excluding the department of financial services, provided however, the department of financial services shall be considered a government entity for purposes of claims or proceedings filed by it against Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil- Janssen Pharmaceuticals, Inc., and/or Janssen Pharmaceutica, Inc.; the superintendent of the department of financial services[,]; and [the New York liquidation bureau, provided however it shall not include] the department of law; and

(ii) any governmental subdivision within the boundaries of the state of New York, including, but not limited to, counties, municipalities, districts, towns and/or villages, and any of their subdivisions, special districts and school districts, and any department, agency, division, board, commission and/or instrumentality thereof.

3. "Participating entities" means participating entities as such term is defined in any statewide opioid settlement agreement.

4. "Opioid settlement fund" means the fund created by [the statewide opioid agreements and] section ninety-nine-nn of the state finance law, the funds of which shall be used or distributed by the commissioners, as authorized by the legislature by statute or appropriation, for the purposes of preventing addiction and reducing the harms caused by the overdose and substance use disorder epidemic consistent with the terms of any statewide opioid settlement agreement.

5. "Released claims" means released claims as such term is defined in the statewide opioid settlement agreements.

6. "Released entities" means released entities as such term is defined in the statewide opioid settlement agreements.

7. "New York subdivisions" means each county, city, town, village, or special district in the state of New York.

8. "Statewide opioid settlement agreements" means agreements of statewide applicability entered into on or after June first, two thousand twenty-one by the office of the attorney general, including but not limited to consent judgments, consent decrees filed or unfiled, and related agreements or documents between the state and certain opioid manufacturers, distributors, dispensers, consultants, chain pharmacies, related entities, and/or the New York subdivisions, to provide remuneration for conduct related to the manufacture, promotion, dispensing, sale, and/or distribution of opioid products which are consistent with subdivision sixteen of section sixty-three of the executive law. Copies of such agreements, including any amendments thereto, shall be kept on file by the attorney general, who shall make such available for inspection and copying pursuant to the provisions of article six of the public officers law.

(b) Eligible expenditures for opioid settlement funds. 1. The legislature shall appropriate funds to be used for eligible expenditures that are consistent with the approved uses and terms of the statewide opioid settlement agreement. Such expenditures shall be distributed regionally and in accordance with the statewide opioid settlement agreements to ensure adequate geographic disbursement across the state.

2. New York subdivisions [shall] may apply to the appropriate agency for funding for eligible expenditures consistent with the terms of any statewide opioid settlement agreement. Any New York subdivision which receives funding pursuant to this section shall be required to annually certify to the appropriate state agency in which funding was received that such New York subdivision is utilizing such funds in accordance with the requirements of this section and section ninety-nine-nn of the state finance law.

3. Each New York subdivision shall provide a detailed accounting of how the funds were used as well as an analysis and evaluation of the services and programs funded. Such information shall be included in the report provided pursuant to paragraph ten of subdivision (c) of this section.

(c) Advisory board establishment and responsibilities. 1. The opioid settlement board is hereby established under the office of addiction services and supports to provide recommendations on how funding received by the opioid settlement fund pursuant to section ninety-nine-nn of the state finance law shall be allocated by the legislature. Recommendations shall be [evidenced-based] evidence-based and may take into consideration federal, state or local initiatives and activities that have shown to be effective in preventing and treating substance use disorders as well as maintaining recovery and assisting with the collateral effects of substance use disorders for individuals and their families or support system. Such recommendations shall also take into account any gaps in access to services or programs identified as eligible expenditures and incorporate mechanisms for measurable outcomes for determining the effectiveness of funds expended. The office and any other relevant agency that provides or regulates eligible expenditures shall provide any necessary staff, resources and technical assistance to assist with the functions of the advisory board. Such assistance shall be supported pursuant to an appropriation by the legislature, in accordance with the statewide opioid settlement agreements.

2. The opioid settlement board may make recommendations to the legislature and the governor regarding the addition or removal of any eligible expenditures in response to changing substance use disorder needs in the state. No recommendation may be made to remove an eligible expenditure without three-fourths approval of present board members.

3. The opioid settlement board shall consist of [nineteen] twenty-one members appointed as follows:

(i) the commissioner of addiction services and supports, the commissioner of mental health, [and] the commissioner of health, and the director of the division of budget, or their designees[, serving as ex-officio non-voting members];

(ii) two appointments by the governor;

(iii) [two] three appointments by the temporary president of the senate;

(iv) [two] three appointments by the speaker of the assembly;

(v) [two] one appointments by the attorney general;

(vi) one appointment by the mayor of the city of New York; and

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the state finance law, the mental hygiene law and the executive law, in relation to establishing an opioid settlement fund

Purpose

To make amendments to the opioid settlement fund and other relevant sections.

Summary of provisions

This bill amends chapter 190 of the laws of 2021 relating to the opioid settlement fund.

Section one of the bill ensures that money expended from the fund would be used consistently with the terms of any statewide opioid settlement agreement as defined in section 25.18 of the Mental Hygiene Law.

Section two of the bill was amended to ensure such expenditures are limited to the defined uses. Additionally, the definition of "government entity" was amended to exclude the Department of Financial Services, provided however, such Department would be considered a government enti- ty for the purposes of claims or proceedings filed by it against Johnson & Johnson, Jansen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceu- ticals, Inc., and/ or Janssen Pharmaceutica, Inc. The definition of "statewide opioid settlement agreements" was amended to ensure that it captured agreements entered into on or after June first, 2021, by the Attorney General's office. Finally, the composition of the opioid settlement board was restructured to include additional members.

Section three ensures that funds received by the State through opioid settlement agreements can be expended by State Agencies on eligible expenditures.

Section four excludes funds deposited into the opioid settlement fund from being deposited into the State's General Fund.

Section five establishes the effective date.

Justification

This bill would ensure further consistency with the terms of any state- wide opioid settlement agreement.

Legislative history

This is a new bill.

Fiscal implications

To be determined.

Effective date

This act shall take effect on the same date and in the same manner as a chapter of the laws of 2021 amending the mental hygiene law relating to establishing a council for treatment equity within the office of addiction services and supports, as proposed in legislative bills numbers S. 679-A and A. 1927-A, takes effect.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.